🇺🇸 Consolidation durvalumab in United States

Consolidation durvalumab (Consolidation durvalumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Consolidation durvalumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Consolidation durvalumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Consolidation durvalumab in United States?

Rachel Sanborn is the originator. The local marketing authorisation holder may differ — check the official source linked above.